Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I First in Human Study to Assess Safety and Immunogenicity of the Human Cytomegalovirus Vaccine Candidate SPYVLP01 With and Without Adjuvants in Healthy Adult Volunteers

NCT06145178 is registered in ClinicalTrials.gov with SpyBiotech Limited as lead sponsor.

NCT NCT06145178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06145178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I First in Human Study to Assess Safety and Immunogenicity of the Human Cytomegalovirus Vaccine Candidate SPYVLP01 With and Without Adjuvants in Healthy Adult Volunteers
Lead sponsor
SpyBiotech Limited
Phase
Phase 1
Overall status
Completed
Start date
November 22, 2023
Completion date
July 9, 2025
Enrollment
120 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus infections